Literature DB >> 17095884

Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients.

Yoshiaki Kiuchi1, Reiko Sugimoto, Kazuto Nakae, Yoshihiro Saito, Shigeo Ito.   

Abstract

BACKGROUND: To assess the efficacy and to determine the risk factors of trabeculectomy with mitomycin C (MMC) in eyes with neovascular glaucoma (NVG) secondary to diabetic retinopathy.
METHODS: Kaplan-Meier survival analysis of the surgical outcome was performed on 35 eyes with NVG. Age, extent of peripheral anterior synechia, surgical history (cataract, glaucoma, vitrectomy), and concurrent retinal cryotherapy were evaluated to determine factors influencing the surgical outcome. The main criterion for success was a postoperative intraocular pressure (IOP) of < or = 21 mm Hg.
RESULTS: The cumulative probability of success was 67.0% at 1 year and 61.8% after 2 to 3 years. The surgical outcome was significantly better in patients without a previous vitrectomy (p = 0.03). Extensive preoperative peripheral anterior synechia was also a risk factor for surgical failure (p = 0.013).
CONCLUSIONS: Trabeculectomy with MMC can effectively reduce the elevated IOP associated with NVG. The extent of peripheral anterior synechia and a history of vitrectomy are significant negative predictors of surgical outcome. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095884     DOI: 10.1159/000095865

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  16 in total

1.  One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy.

Authors:  A Miki; Y Oshima; Y Otori; K Matsushita; K Nishida
Journal:  Eye (Lond)       Date:  2011-03-18       Impact factor: 3.775

2.  Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.

Authors:  Yosuke Sugimoto; Hideki Mochizuki; Hideaki Okumichi; Masaya Takumida; Michiya Takamatsu; Seiichi Kawamata; Yoshiaki Kiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-04       Impact factor: 3.117

3.  Long-term outcomes of glaucoma drainage devices for glaucoma post-vitreoretinal surgery with silicone oil insertion: a prospective evaluation.

Authors:  Shikha Gupta; Abadh K Chaurasia; Rohan Chawla; Kulwant Singh Kapoor; Karthikeyan Mahalingam; Deepa R Swamy; Viney Gupta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-18       Impact factor: 3.117

4.  Prognostic risk factors for failure of trabeculectomy with mitomycin C after vitrectomy.

Authors:  Toshihiro Inoue; Masaru Inatani; Yuji Takihara; Nanako Awai-Kasaoka; Minako Ogata-Iwao; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2012-08-02       Impact factor: 2.447

5.  Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma.

Authors:  Christopher C Shen; Sarwat Salim; Haiming Du; Peter A Netland
Journal:  Clin Ophthalmol       Date:  2011-03-01

6.  A new manner of reporting pressure results after glaucoma surgery.

Authors:  Constantin-Dan Bordeianu; Cristina-Eugenia Ticu
Journal:  Clin Ophthalmol       Date:  2011-12-30

7.  Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma.

Authors:  Tomomi Higashide; Shinji Ohkubo; Kazuhisa Sugiyama
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

8.  Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.

Authors:  Shunji Nakatake; Shigeo Yoshida; Shintaro Nakao; Ryoichi Arita; Miho Yasuda; Takeshi Kita; Hiroshi Enaida; Yuji Ohshima; Tatsuro Ishibashi
Journal:  BMC Ophthalmol       Date:  2014-04-26       Impact factor: 2.209

9.  Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series.

Authors:  Carlos Gustavo Vasconcelos de Moraes; Antonio Carlos Facio; José Humberto Costa; Roberto Freire Santiago Malta
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-31

10.  Outcomes of Ahmed glaucoma valve and transscleral cyclophotocoagulation in neovascular glaucoma.

Authors:  Wesam S Shalaby; Allen Y Ganjei; Brian Wogu; Jonathan S Myers; Marlene R Moster; Reza Razeghinejad; Daniel Lee; Natasha N Kolomeyer; Tarek E Eid; L Jay Katz; Aakriti G Shukla
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.